A platform of assays for the discovery of anti-Zika small-molecules with activity in a 3D-bioprinted outer-blood-retina model.
A platform of assays for the discovery of anti-Zika small-molecules with activity in a 3D-bioprinted outer-blood-retina model.
复制标题
DOI:
10.1371/journal.pone.0261821
复制
发表时间:
2022
期刊:
影响因子:
3.7
通讯作者:
Simeonov A
中科院分区:
文献类型:
--
作者:
Dorjsuren D;Eastman RT;Song MJ;Yasgar A;Chen Y;Bharti K;Zakharov AV;Jadhav A;Ferrer M;Shi PY;Simeonov A
The global health emergency posed by the outbreak of Zika virus (ZIKV), an arthropod-borne flavivirus causing severe neonatal neurological conditions, has subsided, but there continues to be transmission of ZIKV in endemic regions. As such, there is still a medical need for discovering and developing therapeutical interventions against ZIKV. To identify small-molecule compounds that inhibit ZIKV disease and transmission, we screened multiple small-molecule collections, mostly derived from natural products, for their ability to inhibit wild-type ZIKV. As a primary high-throughput screen, we used a viral cytopathic effect (CPE) inhibition assay conducted in Vero cells that was optimized and miniaturized to a 1536-well format. Suitably active compounds identified from the primary screen were tested in a panel of orthogonal assays using recombinant Zika viruses, including a ZIKV Renilla luciferase reporter assay and a ZIKV mCherry reporter system. Compounds that were active in the wild-type ZIKV inhibition and ZIKV reporter assays were further evaluated for their inhibitory effects against other flaviviruses. Lastly, we demonstrated that wild-type ZIKV is able to infect a 3D-bioprinted outer-blood-retina barrier tissue model and disrupt its barrier function, as measured by electrical resistance. One of the identified compounds (3-Acetyl-13-deoxyphomenone, NCGC00380955) was able to prevent the pathological effects of the viral infection on this clinically relevant ZIKV infection model.
登录
查看更多内容
影响因子:
3.8
作者:
CABRAL, GA;MCNERNEY, PJ;MISHKIN, EM
通讯作者:
MISHKIN, EM
影响因子:
39.2
作者:
Costa F;Sarno M;Khouri R;de Paula Freitas B;Siqueira I;Ribeiro GS;Ribeiro HC;Campos GS;Alcântara LC;Reis MG;Weaver SC;Vasilakis N;Ko AI;Almeida AR
通讯作者:
Almeida AR
影响因子:
30.3
作者:
Barrows NJ;Campos RK;Powell ST;Prasanth KR;Schott-Lerner G;Soto-Acosta R;Galarza-Muñoz G;McGrath EL;Urrabaz-Garza R;Gao J;Wu P;Menon R;Saade G;Fernandez-Salas I;Rossi SL;Vasilakis N;Routh A;Bradrick SS;Garcia-Blanco MA
通讯作者:
Garcia-Blanco MA
DOI:
10.1111/cts.12570
发表时间:
2018-09
期刊:
Clinical and translational science
影响因子:
--
作者:
Coussens NP;Sittampalam GS;Guha R;Brimacombe K;Grossman A;Chung TDY;Weidner JR;Riss T;Trask OJ;Auld D;Dahlin JL;Devanaryan V;Foley TL;McGee J;Kahl SD;Kales SC;Arkin M;Baell J;Bejcek B;Gal-Edd N;Glicksman M;Haas JV;Iversen PW;Hoeppner M;Lathrop S;Sayers E;Liu H;Trawick B;McVey J;Lemmon VP;Li Z;McManus O;Minor L;Napper A;Wildey MJ;Pacifici R;Chin WW;Xia M;Xu X;Lal-Nag M;Hall MD;Michael S;Inglese J;Simeonov A;Austin CP
通讯作者:
Austin CP
影响因子:
--
作者:
Eyer L;Nencka R;de Clercq E;Seley-Radtke K;Růžek D
通讯作者:
Růžek D